
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
The Long Run with Luke Timmerman
Gene Logic - How Did You End Up at Pfizer?
Gene logic was actually going through a lot of changes had just gotten a new CEO. So I made the decision to go over to Pfizer in part because of business development and the ability to deepen my skills there. And also, you know, when at least my experience in biotech was I always wondered like within big pharma, how does all of this knit together? We've got a piece of it there integrating all of it. How does that fit together?
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.